
Journeys Metabolic: A digital platform for metabolic care, improving clinical outcomes with personalized, physician-developed programs.
Journeys Metabolic is the first enterprise intervention platform that helps value-based organizations improve clinical and financial outcomes for metabolic disease. The HITRUST, EHR-interoperable platform supports population-wide reversal and prevention of metabolic disease via an automated provider workflow engaging qualified targeted patient populations, including those with type 2 diabetes, NAFLD, metabolic syndrome, and obesity. The core clinical component is a 4-month, physician-developed, digital program that leverages personalized educational content delivery, computer vision for food tracking, and a proprietary metabolic biomarker device.
To date, 3,000+ patients have benefited from the protocol and outcomes include a sustainable average 8% body weight loss, 17% A1c reduction, and 54% NAFLD resolution with significant biomarker improvements targeting HEDIS scores. Journeys Metabolic is a trusted source for health systems and accountable care organizations focused on transforming their chronic care solutions and achieving a fee-for-outcomes reality. The company was founded in 2018 and is based in St. Louis, Missouri. For more information, visit journeysmetabolic.com.

Calibrate
joincalibrate.com

Virta Health
virtahealth.com

9amHealth
join9am.com

MetaLogics

twenty30 health
twenty30.health

Twin Health
twinhealth.com

Digbi Health
digbihealth.com

Intellihealth
intellihealth.co

metaMe Health
metamehealth.com

Signos
signos.com

Wellest
wellest.com

Measured
trymeasured.com

Levels
levelshealth.com

One Drop
onedrop.today

Thrive365
thrive365.com
Companies similar to Journeys Metabolic include Calibrate, Virta Health, 9amHealth and MetaLogics.
Journeys Metabolic was founded in 2019.
Journeys Metabolic's headquarters is located in St. Louis, MO, US.
As of Feb 20, 2023, Journeys Metabolic has raised a total of $3.1M (USD).
Journeys Metabolic has 35 employees as of Feb 4, 2024.